OTCMHADV
Market cap80kUSD
Dec 24, Last price
0.00USD
1D
0.00%
1Q
-41.18%
Jan 2017
-99.58%
IPO
-99.67%
Name
Health Advance Inc
Chart & Performance
Profile
Health Advance Inc., a development stage company, operates as an on-line retailer of home medical products in Canada and the United States. It intends to offers aids to daily living, ambulatory, bath safety, core wound care, diabetic, enteral nutrition-feeding, home diagnostics, incontinence, orthopedic, ostomy, pain management, professional use and diagnostic, respiratory, tracheostomy care, specialty wound care, and women-infant products. The company's product portfolio would also include bed accessories, catheters, diagnostic equipment, lift chairs/geri chairs, IV supplies, needles/syringes, patient lifts and acc, personal protection products/gloves, scooters and accessories, seating/cushions, specialty medical equipment and accessories, urological/collection devices, wheelchairs accessories. It focuses on operating leadingmedicalproducts.com, an e-commerce site for the retail community and health care community. The company intends to serve health care professionals, medical distributors, and consumers. Health Advance Inc. was founded in 2010 and is based in Las Vegas, Nevada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|
2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2016‑07 | 2015‑07 | |
Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | (49) | |||||
Tax Rate | ||||||
NOPAT | 49 | |||||
Net income | (49) -81.82% | (270) 106.38% | (131) -870.99% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 250 | |||||
BB yield | ||||||
Debt | ||||||
Debt current | 18 | 14 | ||||
Long-term debt | 254 | 254 | 235 | |||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | 272 | 268 | 235 | |||
Cash flow | ||||||
Cash from operating activities | (12) | (273) | (197) | |||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | 280 | 196 | ||||
FCF | 86 | (4) | (72) | |||
Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | (228) | (179) | (159) | |||
Invested Capital | 461 | 457 | 427 | |||
ROIC | 10.68% | |||||
ROCE | ||||||
EV | ||||||
Common stock shares outstanding | 185,948 | 185,948 | 160,948 | |||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT |